Publications
January 2021
October 2020
Technology and Liability of the Managing Director
June 2020
July 2018
Patentverletzung im Hinblick auf den 3D-Druck und Geschäftsführerhaftung
Author: Dr. Marc Gerauer
June 2018
Das CRISPR/Cas-System - Der nächste Quantensprung in der Molekularbiologie
Author: Dr. Oliver Ladendorf
May 2017
Patentability of products obtained by essentially biological processes in Europe
Authors: Dr. Oliver Ladendorf, Dr. Evy Corbanie
April 2016
What is the relevant date of marketing authorization to determine the term of an SPC?
Authors: Dr. Oliver Ladendorf, Dr. Alexander Kleefen
April 2016
May a part of a fusion protein be considered an "active ingredient"?
Yes, says the ECJ in Forsgren
Authors: Dr. Oliver Ladendorf, Dr. Alexander Kleefen
March 2016
Eli Lilly vs. HGS (C-493/12):
The UK High Court clarifies the ECJ's enigmatic decision
Authors: Dr. Oliver Ladendorf, Dr. Alexander Kleefen
Contact
KRAUS & WEISERT
Patentanwälte PartGmbB
European Patent and Trademark Attorneys
Thomas-Wimmer-Ring 15 | 80539 Munich | Germany
T +49 89 29060 - 0 | F +49 89 29060 - 111
www.kraus-weisert.de | This email address is being protected from spambots. You need JavaScript enabled to view it.
Proud to be honoured
We have received awards from renowned national and international handbooks, magazines, newspapers and international professional journals and are proud when good work is recognized.
News
Recap of Kraus & Weisert 2023 seminar
A compilation of videos covering the presentations and the Q&A sections of Kraus & Weisert's seminar on recent trends in artificial intelligence …
The EPO's "10-day notification rule"
On and after November 1, 2023 the EPO's "10-day notification rule" will no longer apply to communications issued by the EPO.
of the Boards of Appeal